{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T14:36:08Z","timestamp":1781274968176,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002660","name":"Islamic Azad University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002660","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["New Microbes and New Infections"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.nmni.2024.101437","type":"journal-article","created":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T05:25:42Z","timestamp":1716701142000},"page":"101437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Delamanid and bedaquiline resistance patterns in Mycobacterium tuberculosis in Iran: A cross-sectional analysis"],"prefix":"10.1016","volume":"60-61","author":[{"given":"AmirHossein","family":"Akbari Aghababa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3279-0671","authenticated-orcid":false,"given":"Mohammad Javad","family":"Nasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parviz","family":"Pakzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnaz Sadat","family":"Mirsamadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.nmni.2024.101437_bib1","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.ajic.2014.07.017","article-title":"Prevalence of drug-resistant tuberculosis in Iran: systematic review and meta-analysis","volume":"42","author":"Nasiri","year":"2014","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.nmni.2024.101437_bib2","article-title":"Trends in multidrug-resistant tuberculosis in Tehran, Iran: an analysis of published data","volume":"14","author":"Nasiri","year":"2019","journal-title":"GMS Hygiene Infect. Control"},{"key":"10.1016\/j.nmni.2024.101437_bib3","series-title":"Module 4: treatment-drug-resistant tuberculosis treatment","year":"2022"},{"issue":"10","key":"10.1016\/j.nmni.2024.101437_bib4","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1901814","article-title":"Treatment of highly drug-resistant pulmonary tuberculosis","volume":"382","author":"Conradie","year":"2020","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.nmni.2024.101437_bib5","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1473-3099(10)70139-0","article-title":"Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis","volume":"10","author":"Caminero","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.nmni.2024.101437_bib6","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/j.ijid.2022.02.043","article-title":"Delamanid-containing regimens and multidrug-resistant tuberculosis: a systematic review and meta-analysis","volume":"124","author":"Nasiri","year":"2022","journal-title":"Int J Infect Dis"},{"issue":"23","key":"10.1016\/j.nmni.2024.101437_bib7","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa1112433","article-title":"Delamanid for multidrug-resistant pulmonary tuberculosis","volume":"366","author":"Gler","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmni.2024.101437_bib8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tube.2017.12.006","article-title":"Mechanisms of resistance to delamanid, a drug for Mycobacterium tuberculosis","volume":"108","author":"Fujiwara","year":"2018","journal-title":"Tuberculosis"},{"issue":"12","key":"10.1016\/j.nmni.2024.101437_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00531-22","article-title":"Spontaneous mutational patterns and novel mutations for delamanid resistance in Mycobacterium tuberculosis","volume":"66","author":"Liu","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.nmni.2024.101437_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01304-20","article-title":"Characterization of genomic variants associated with resistance to bedaquiline and delamanid in naive Mycobacterium tuberculosis clinical strains","volume":"58","author":"Battaglia","year":"2020","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.nmni.2024.101437_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98862-4","article-title":"Genetic diversity of candidate loci linked to Mycobacterium tuberculosis resistance to bedaquiline, delamanid and pretomanid","volume":"11","author":"G\u00f3mez-Gonz\u00e1lez","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.nmni.2024.101437_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-36955-y","article-title":"Bedaquiline-and clofazimine-selected Mycobacterium tuberculosis mutants: further insights on resistance driven largely by Rv0678","volume":"13","author":"Snobre","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.nmni.2024.101437_bib13","article-title":"Bedaquiline-containing regimens and multidrug-resistant tuberculosis: a systematic review and meta-analysis","volume":"48","author":"Hatami","year":"2022","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.nmni.2024.101437_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.807095","article-title":"Whole genome sequencing identifies novel mutations associated with bedaquiline resistance in mycobacterium tuberculosis","volume":"12","author":"Guo","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.nmni.2024.101437_bib15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ddr.21498","article-title":"Bedaquiline and delamanid in the treatment of multidrug\u2010resistant tuberculosis: promising but challenging","volume":"80","author":"Li","year":"2019","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.nmni.2024.101437_bib16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jgar.2021.06.007","article-title":"Prevalence of Mycobacterium tuberculosis resistant to bedaquiline and delamanid in China","volume":"26","author":"He","year":"2021","journal-title":"J. Global Antimicro. Resist."},{"issue":"10","key":"10.1016\/j.nmni.2024.101437_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00900-17","article-title":"In vitro drug susceptibility of bedaquiline, delamanid, linezolid, clofazimine, moxifloxacin, and gatifloxacin against extensively drug-resistant tuberculosis in Beijing, China","volume":"61","author":"Pang","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nmni.2024.101437_bib18","series-title":"Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes","author":"Woods","year":"2011"},{"key":"10.1016\/j.nmni.2024.101437_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmni.2020.100665","article-title":"High-resolution melt curve analysis for rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a single-centre study in Iran","volume":"35","author":"Arefzadeh","year":"2020","journal-title":"New Microb. New Infect."},{"key":"10.1016\/j.nmni.2024.101437_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmni.2020.100729","article-title":"Genotyping and drug susceptibility testing of Mycobacterium tuberculosis in Iran: a multi-centre study","volume":"37","author":"Mousavi","year":"2020","journal-title":"New Microb. New Infect."},{"key":"10.1016\/j.nmni.2024.101437_bib21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.nmni.2017.08.008","article-title":"High rates of nontuberculous mycobacteria isolation from patients with presumptive tuberculosis in Iran","volume":"21","author":"Nasiri","year":"2018","journal-title":"New Microb. New Infect."},{"key":"10.1016\/j.nmni.2024.101437_bib22","series-title":"Technical manual for drug susceptibility testing of medicines used in the treatment of tuberculosis","author":"Organization","year":"2018"},{"issue":"1","key":"10.1016\/j.nmni.2024.101437_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-021-06024-8","article-title":"Molecular characterization of multidrug-resistant tuberculosis against levofloxacin, moxifloxacin, bedaquiline, linezolid, clofazimine, and delamanid in southwest of China","volume":"21","author":"Zheng","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.nmni.2024.101437_bib24","doi-asserted-by":"crossref","first-page":"e938","DOI":"10.1093\/cid\/ciac528","article-title":"Bedaquiline, delamanid, linezolid, and clofazimine for treatment of pre-extensively drug-resistant tuberculosis","volume":"76","author":"Padmapriyadarsini","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.nmni.2024.101437_bib25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijtb.2023.05.005","article-title":"Efficacy and safety of bedaquiline and delamanid in the treatment of drug-resistant tuberculosis in adults: a systematic review and meta-analysis","volume":"71","author":"Ahmed","year":"2023","journal-title":"Indian J Tubercul"},{"key":"10.1016\/j.nmni.2024.101437_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1183597","article-title":"Advances of new drugs bedaquiline and delamanid in the treatment of multi-drug resistant tuberculosis in children","volume":"13","author":"Zhu","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"10.1016\/j.nmni.2024.101437_bib27","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3201\/eid2905.221716","article-title":"Therapeutic failure and acquired bedaquiline and delamanid resistance in treatment of drug-resistant TB","volume":"29","author":"Millard","year":"2023","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.nmni.2024.101437_bib28","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/jac\/dkw044","article-title":"Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC\u2122 MGIT\u2122 960 system","volume":"71","author":"Schena","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.nmni.2024.101437_bib29","doi-asserted-by":"crossref","first-page":"5316","DOI":"10.1128\/AAC.00308-15","article-title":"Mutations in genes for the F420 biosynthetic pathway and a nitroreductase enzyme are the primary resistance determinants in spontaneous in vitro-selected PA-824-resistant mutants of Mycobacterium tuberculosis","volume":"59","author":"Haver","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nmni.2024.101437_bib30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.tube.2018.04.008","article-title":"Delamanid: from discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB)","volume":"111","author":"Liu","year":"2018","journal-title":"Tuberculosis"},{"issue":"12","key":"10.1016\/j.nmni.2024.101437_bib31","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.1128\/AAC.05500-11","article-title":"Impact of Fgd1 and ddn diversity in Mycobacterium tuberculosis complex on in vitro susceptibility to PA-824","volume":"55","author":"Feuerriegel","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.nmni.2024.101437_bib32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12866-022-02475-4","article-title":"Variants associated with Bedaquiline (BDQ) resistance identified in Rv0678 and efflux pump genes in Mycobacterium tuberculosis isolates from BDQ na\u00efve TB patients in Pakistan","volume":"22","author":"Saeed","year":"2022","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.nmni.2024.101437_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2022.102266","article-title":"Bedaquiline resistant Mycobacterium tuberculosis clinical isolates with and without rv0678 mutations have similar growth patterns under varying BDQ drug pressure","volume":"137","author":"Saeed","year":"2022","journal-title":"Tuberculosis"},{"issue":"8","key":"10.1016\/j.nmni.2024.101437_bib34","doi-asserted-by":"crossref","first-page":"646","DOI":"10.5588\/ijtld.23.0123","article-title":"High prevalence of multidrug-resistant TB among household contacts in a high burden setting","volume":"27","author":"Ahmed","year":"2023","journal-title":"Int J Tubercul Lung Dis"}],"container-title":["New Microbes and New Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S205229752400221X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S205229752400221X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T16:53:35Z","timestamp":1722099215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S205229752400221X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":34,"alternative-id":["S205229752400221X"],"URL":"https:\/\/doi.org\/10.1016\/j.nmni.2024.101437","relation":{},"ISSN":["2052-2975"],"issn-type":[{"value":"2052-2975","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delamanid and bedaquiline resistance patterns in Mycobacterium tuberculosis in Iran: A cross-sectional analysis","name":"articletitle","label":"Article Title"},{"value":"New Microbes and New Infections","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmni.2024.101437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101437"}}